Stereotaxis, Inc.
STXSAMEXHealthcare● Active
$1.81
+$0.03(+1.69%)
Market Cap$176903427
P/E Ratio—
52W High$3.59
52W Low$1.7
Stereotaxis, Inc. (STXS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
STXS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.03
Est. -$0.04 · +25.0%
Revenue
$0.01B
Est. $0.01B · -26.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
STXS reports quarterly as a AMEX-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.52
Rev. $3.34B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.52
Rev. Est.$3.34B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.03 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 12, 2026 | -$0.04 | -$0.03 | +25.0% | $0.01B | $0.01B | -26.0% |
| — Q1 FY2026 | Mar 9, 2026 | -$0.06 | -$0.06 | +0.0% | $0.01B | $0.01B | -4.8% |
| ▲ Q4 FY2025 | Nov 11, 2025 | -$0.06 | -$0.03 | +50.0% | $0.01B | $0.01B | -19.2% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.07 | -$0.05 | +28.6% | $0.01B | $0.01B | +4.3% |
| — Q2 FY2025 | May 12, 2025 | -$0.07 | -$0.07 | +0.0% | $0.01B | $0.01B | -3.3% |
| ▼ Q1 FY2025 | Mar 3, 2025 | -$0.06 | -$0.09 | -50.0% | $0.01B | $0.01B | -5.4% |
| ▼ Q4 FY2024 | Nov 11, 2024 | -$0.05 | -$0.08 | -60.0% | $0.01B | $0.01B | +43.1% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.04
EPS Surpr.
+25.0%
Revenue
$0.01B
Q1 FY2026
Mar 9, 2026
EPS Actual
-$0.06
EPS Est.
-$0.06
EPS Surpr.
+0.0%
Revenue
$0.01B
Q4 FY2025
Nov 11, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.06
EPS Surpr.
+50.0%
Revenue
$0.01B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.05
EPS Est.
-$0.07
EPS Surpr.
+28.6%
Revenue
$0.01B
Q2 FY2025
May 12, 2025
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.01B
Q1 FY2025
Mar 3, 2025Miss
EPS Actual
-$0.09
EPS Est.
-$0.06
EPS Surpr.
-50.0%
Revenue
$0.01B
Q4 FY2024
Nov 11, 2024Miss
EPS Actual
-$0.08
EPS Est.
-$0.05
EPS Surpr.
-60.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q2 FY2027 | $-0.03 | $-0.03 | $-0.02 | 1 |
| Q1 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q4 FY2026 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2026 | $-0.05 | $-0.05 | $-0.04 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +25.0% | $1.88 | $1.92 | +2.13% |
| ▲ Q1 FY2026 | Mar 9, 2026 | +0.0% | $2.05 | $2.07 | +0.98% |
| ▲ Q4 FY2025 | Nov 11, 2025 | +50.0% | $2.79 | $2.85 | +2.15% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +28.6% | $2.25 | $2.19 | -2.67% |
| ▲ Q2 FY2025 | May 12, 2025 | +0.0% | $2.13 | $2.07 | -2.82% |
| ▼ Q1 FY2025 | Mar 3, 2025 | -50.0% | $2.06 | $1.94 | -5.83% |
| ▼ Q4 FY2024 | Nov 11, 2024 | -60.0% | $1.87 | $1.85 | -1.07% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -33.3% | $1.87 | $1.80 | -3.74% |
Q2 FY2026+2.13%
Report Date
May 12, 2026
EPS Beat/Miss
+25.0%
Price Before
$1.88
Price After
$1.92
Q1 FY2026+0.98%
Report Date
Mar 9, 2026
EPS Beat/Miss
+0.0%
Price Before
$2.05
Price After
$2.07
Q4 FY2025+2.15%
Report Date
Nov 11, 2025
EPS Beat/Miss
+50.0%
Price Before
$2.79
Price After
$2.85
Q3 FY2025-2.67%
Report Date
Aug 7, 2025
EPS Beat/Miss
+28.6%
Price Before
$2.25
Price After
$2.19
Q2 FY2025-2.82%
Report Date
May 12, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.13
Price After
$2.07
Q1 FY2025-5.83%
Report Date
Mar 3, 2025
EPS Beat/Miss
-50.0%
Price Before
$2.06
Price After
$1.94
Q4 FY2024-1.07%
Report Date
Nov 11, 2024
EPS Beat/Miss
-60.0%
Price Before
$1.87
Price After
$1.85
Q3 FY2024-3.74%
Report Date
Aug 12, 2024
EPS Beat/Miss
-33.3%
Price Before
$1.87
Price After
$1.80
Avg Beat Reaction-0.05%
Avg Miss Reaction-3.55%
Beat Rate5 / 8 quarters
Largest Move-5.83% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: STXS ends December
Stereotaxis, Inc. (STXS) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.03 — beating the analyst consensus of $-0.04 by +25.0%. STXS has beaten EPS estimates for 5 consecutive quarters. The next STXS earnings date is expected around September 1, 2026.
Each quarter, investors track STXS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. STXS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
STXS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
STXS earnings · 5 questionsStereotaxis, Inc.'s next earnings report is expected around September 1, 2026. STXS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; STXS historically reports after market close (AMC).
STXS earnings datewhen is STXS earningsSTXS next earnings datewhen does STXS report earningsSTXS earnings calendar
▸ Source: FMP · Stereotaxis, Inc. SEC filings · US GAAP · Stereotaxis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026